(1) Whether, in accordance with the National Drug Master Plan, her department has introduced performance indicators to monitor the (a) effectiveness and (b) progress of action plans at all levels; if not, why not, if so, what are the relevant details; (2) whether the Central Drug Authority (CDA) currently monitors the (a) effectiveness and (b) progress of each department’s Mini Drug Master Plan; if not, what is the position in this regard; if so, what are the relevant details?